EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated ApoC3 levels in cerebrospinal fluid predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage

Bin Tong, Junjie Wang, Jiarui Chen, Qia Zhang, Zhouhan Xu, Kaichuang Yang, Xiaomin Chen

Experimental Biology and Medicine · 17.04.2026 · 251

DOI: 10.3389/ebm.2026.10827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, online erschienen am 17.04.2026. Verfasst von Bin Tong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of the Operating Room, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Apolipoprotein C-III. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating condition associated with approximately 30% mortality and 20% severe disability among survivors. Delayed cerebral ischemia due to cerebral vasospasm and hydrocephalus significantly contribute to poor neurological outcomes. Currently, reliable biomarkers for early prediction of these complications remain lacking. In this study, 63 patients with a mean age of 59.7 ± 11.53 years were enrolled. Functional outcomes were assessed by the modified Rankin Scale (mRS). Cerebrospinal fluid (CSF) samples were obtained through lumbar drainage (LD) or external ventricular drainage (EVD) and analyzed by ELISA. The predictive value of biomarkers was evaluated using receiver operating characteristic (ROC) curve analysis. Elevated Apolipoprotein C-III (ApoC3) levels in CSF of aSAH patients were observed. Furthermore, increased ApoC3 concentrations were significantly associated with poor prognosis and an elevated risk of severe complications. At an optimal cutoff value of 4,463 ng/mL, patients with high ApoC3 levels exhibited significantly worse 3-month functional outcomes and a higher incidence of delayed cerebral ischemia and hydrocephalus. Monitoring ApoC3 levels in CSF may be beneficial for predicting complications such as delayed cerebral ischemia and hydrocephalus in patients with aSAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageApolipoprotein C-IIIHumansFemaleMaleMiddle AgedBiomarkersPrognosisAgedBrain IschemiaHydrocephalusROC CurveVasospasm, IntracranialAdult

Stichwörter der Autor:innen

ApoC3aneurysmal subarachnoid hemorrhagecerebrospinal fluiddelayed cerebral ischemiahydrocephalus

Substanzen

Apolipoprotein C-IIIBiomarkers

Autor:innen und Institutionen

  • Department of the Operating Room, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Center for Rehabilitation Medicine, Department of Neurosurgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.
  • Department of Nursing, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, China.

Zitieren

APA

Tong, B., Wang, J., Chen, J., Zhang, Q., Xu, Z., Yang, K., & Chen, X. (2026). Elevated ApoC3 levels in cerebrospinal fluid predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage. Experimental Biology and Medicine, 251. https://doi.org/10.3389/ebm.2026.10827

Vancouver

Tong B, Wang J, Chen J, Zhang Q, Xu Z, Yang K, et al. Elevated ApoC3 levels in cerebrospinal fluid predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage. Experimental Biology and Medicine. 2026;251. doi:10.3389/ebm.2026.10827

BibTeX
@article{Tong2026,
  author = {Tong, Bin and Wang, Junjie and Chen, Jiarui and Zhang, Qia and Xu, Zhouhan and Yang, Kaichuang and Chen, Xiaomin},
  title = {Elevated ApoC3 levels in cerebrospinal fluid predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage},
  journal = {Experimental Biology and Medicine},
  year = {2026},
  volume = {251},
  doi = {10.3389/ebm.2026.10827}
}
Kostenlos starten →